Reselute develops solutions for the treatment of orthopaedic implant related infections.
Reselute designs, develops, and validates the proof of concept for an orthopaedic spacer using innovative technologies, enabling doctors to accelerate treatment and improve patient care. They develop medical devices intended for the treatment of orthopaedic implant-related infections.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Feb 5, 2022 | Grant | $255.24K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |